
Rabzorab Ultra 30mg/40mg Capsule SR
Marketer
Human Biolife India Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (40mg)
Overview Rabzorab Ultra 30mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with the combined-action formulation, Rabzorab Ultra 30mg/40mg Sustained-Release Capsules. This medication alleviates common GERD symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Rabzorab Ultra should be taken on an empty stomach, following your doctor's prescribed dosage and regimen. Treatment duration depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and potential disease exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is crucial, as interactions may occur. Common, usually transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cool milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment outcomes. Pre-treatment disclosure of liver or kidney conditions, pregnancy, pregnancy planning, or breastfeeding is essential.
Uses of Rabzorab Ultra 30mg/40mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabzorab Ultra 30mg/40mg Capsule SR:
Consume Rabzorab Ultra 30mg/40mg SR Capsules as directed by your physician, adhering precisely to the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rabzorab Ultra 30mg/40mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rabzorab Ultra 30mg/40mg Capsule SR:
Consume Rabzorab Ultra 30mg/40mg SR capsules precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.
How Rabzorab Ultra 30mg/40mg Capsule SR works:
Rabzorab Ultra 30mg/40mg sustained-release capsules contain Domperidone and Rabeprazole, two active ingredients working synergistically. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract function, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabzorab Ultra 30mg/40mg SR Capsules with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Rabzorab Ultra 30mg/40mg SR Capsules during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Rabzorab Ultra capsules (30mg/40mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rabzorab Ultra 30mg/40mg sustained-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Rabzorab Ultra 30mg/40mg sustained-release capsules to individuals with impaired renal function. Dosage modification of Rabzorab Ultra 30mg/40mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rabzorab Ultra 30mg/40mg SR capsules; dosage modification may be necessary. Consult a physician before use. Rabzorab Ultra 30mg/40mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rabzorab Ultra 30mg/40mg Capsule SR :
Should you forget to take your Rabzorab Ultra 30mg/40mg Capsule SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabzorab Ultra 30mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
